Stockreport

BioXcel Therapeutics to Highlight Advances in the BXCL501 Program at 2019 Investor Event in New York City

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
PDF Management to unveil BXCL501 global development strategy and agitation franchise expansion Key Opinion Leaders to discuss acute agitation across multiple disease condit [Read more]